...been reported in peer reviewed publications by AUB and NIH. At least one other company, Genprex Inc....

...University of Texas MD Anderson Cancer Center (Houston, Texas) aimed at evaluating the effect of Genprex's...
...anti-CTLA-4 therapies. MD Anderson will provide all necessary personnel, equipment, supplies, facilities and resources for Genprex...
...to treat non-small cell lung cancer (NSCLC). Genprex will pay $2 million to MD Anderson. Genprex Inc....

...4/18/18 $108.0 $414.0 $446.8 8% Medigen Vaccine Biologics Corp. (TPEx:6547) 4/17/18 $17.7 $147.9 $176.6 19% Genprex Inc....

...ProLung Inc. 8/7/17 $7M Devt (diagnostic) Sofiva Genomics Co. Ltd. (TPEx-E:6615) 7/31/17 TBD Mkt (diagnostic) Genprex Inc....

...D) 8/15/17 TBD Mkt (drug) Sofiva Genomics Co. Ltd. (TPEx-E:6615) (D) 7/31/17 TBD Mkt (diagnostic) Genprex Inc....

...On July 20, cancer company Genprex Inc. (Austin, Texas) proposed to raise up to $24.5 million in...
...in a best efforts IPO underwritten by Network 1 Financial Securities. Genprex Inc. , Austin, Texas Julian Zhu Genprex Inc....

...patients and is being conducted at the University of Texas MD Anderson Cancer Center . Genprex Inc....
...dose (MTD); overall response rate (ORR) Status: Interim Phase II data Milestone: NA Jaime De Leon FUS1 nanoparticles Oncoprex Genprex Inc. Tumor...

...for all). Data were presented at the American Association for Cancer Research meeting in Chicago. Genprex...
...Genentech Inc. , a unit of Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland), and by Roche elsewhere. Genprex Inc....